Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

RAC Device Practice Question Set 8, Quizzes of Law

RAC Device Practice Question Set 8- US

Typology: Quizzes

2024/2025

Uploaded on 04/07/2025

sandeep-srivastava-5
sandeep-srivastava-5 🇮🇳

13 documents

1 / 2

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Question
Answer
Explanation
What type of meeting request is used to share information with
FDA without the expectation of feedback from them?
A. Pre-Sub Meeting
B. Informational Meeting
C. Submission Issue Request (SIR)
D. Study Risk Determination Meeting
B. Informational Meeting
RAC Book page 101.
An Informational Meeting allows sponsors to share
information with the FDA, typically about device
development, without expecting feedback. These
meetings can help familiarize FDA reviewers with new
technology or ongoing projects.
In how many days should Q-Sub meeting minutes be provided to
FDA after the meeting has taken place?
A. 10 days
B. 15 days
C. 20 days
B. 15 days
What type of meeting request is used to share information with
FDA without the expectation of feedback from them?
A. Pre-Sub Meeting
B. Informational Meeting
C. Study Risk Determination
D. Submission Issue Request (SIR)
B. Informational Meeting
In what format must Q-Subs be submitted?
A. Paper Submission
B. eCopy
C. Email Submission
D. CD-ROM
B. eCopy Explanation: Under section 745(A)(b) of the FD&C Act,
Q-Subs must be submitted in eCopy format.
What is a Q-Sub supplement?
A. A completely new request for FDA feedback.
B. Any new request for feedback related to an existing Q-Sub.
C. An amendment to the original Q-Sub.
D. A regulatory filing unrelated to the original Q-Sub.
B. Any new request for feedback related to
an existing Q-Sub.
Explanation: A Q-Sub supplement involves seeking
feedback on the same or similar device as the original Q-
Sub.
What is a Q-Sub amendment?
A. A new Q-Sub request.
B. A request for meeting minutes.
C. Additional information related to the original Q-Sub.
D. A revised classification request.
C. Additional information related to the
original Q-Sub.
What is the Pre-Sub method of feedback and timeframe?
A. Written feedback only, 45 days.
B. Meeting with FDA, 90 days.
C. Written feedback or meeting, 70 days.
D. Meeting only, 60 days.
C. Written feedback or meeting, 70 days.
pf2

Partial preview of the text

Download RAC Device Practice Question Set 8 and more Quizzes Law in PDF only on Docsity!

Question Answer Explanation What type of meeting request is used to share information with FDA without the expectation of feedback from them? A. Pre-Sub Meeting B. Informational Meeting C. Submission Issue Request (SIR) D. Study Risk Determination Meeting B. Informational Meeting RAC Book page 101. An Informational Meeting allows sponsors to share information with the FDA, typically about device development, without expecting feedback. These meetings can help familiarize FDA reviewers with new technology or ongoing projects. In how many days should Q-Sub meeting minutes be provided to FDA after the meeting has taken place? A. 10 days B. 15 days C. 20 days D. 30 days B. 15 days What type of meeting request is used to share information with FDA without the expectation of feedback from them? A. Pre-Sub Meeting B. Informational Meeting C. Study Risk Determination D. Submission Issue Request (SIR) B. Informational Meeting In what format must Q-Subs be submitted? A. Paper Submission B. eCopy C. Email Submission D. CD-ROM B. eCopy Explanation: Under section 745(A)(b) of the FD&C Act, Q-Subs must be submitted in eCopy format. What is a Q-Sub supplement? A. A completely new request for FDA feedback. B. Any new request for feedback related to an existing Q-Sub. C. An amendment to the original Q-Sub. D. A regulatory filing unrelated to the original Q-Sub. B. Any new request for feedback related to an existing Q-Sub. Explanation: A Q-Sub supplement involves seeking feedback on the same or similar device as the original Q- Sub. What is a Q-Sub amendment? A. A new Q-Sub request. B. A request for meeting minutes. C. Additional information related to the original Q-Sub. D. A revised classification request. C. Additional information related to the original Q-Sub. What is the Pre-Sub method of feedback and timeframe? A. Written feedback only, 45 days. B. Meeting with FDA, 90 days. C. Written feedback or meeting, 70 days. D. Meeting only, 60 days. C. Written feedback or meeting, 70 days.

What is the SIR (Submission Issue Request) method of feedback and timeframe? A. Written feedback, 45 days. B. Meeting or written feedback, 21 days. C. Written feedback, 30 days. D. Meeting only, 15 days. B. Meeting or written feedback, 21 days. RAC Book page 102. Explanation: A SIR request will result in written feedback within 21 days of receipt of the meeting request. What is the Study Risk Determination method of feedback and timeframe? A. Written feedback, 30 days. B. Meeting only, 60 days. C. Written feedback only, 90 days. D. Written feedback or meeting, 30 days. A. Written feedback, 30 days. What is the Informational Meeting method of feedback and timeframe? A. Written feedback, 45 days. B. No feedback, 60 days. C. Written feedback or meeting, 90 days. D. No feedback, no specified timeframe. D. No feedback, no specified timeframe. What is the role of a Design History File (DHF) in the device development process? A. To demonstrate the financial performance of the device B. To document the design and development stages of a medical device C. To store post-market surveillance data D. To manage device recalls